Previous close | 123.50 |
Open | 129.08 |
Bid | 0.00 x 0 |
Ask | 0.00 x 0 |
Day's range | 123.30 - 130.00 |
52-week range | 74.70 - 140.32 |
Volume | |
Avg. volume | 41,906 |
Market cap | 568.923B |
Beta (5Y monthly) | 0.19 |
PE ratio (TTM) | 46.68 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 1.86 (1.49%) |
Ex-dividend date | 22 Mar 2024 |
1y target est | N/A |
Nvidia and several other leaders flashed buy signals as the market roared. Investors should take advantage, but it's a jungle out there.
Earnings preview of key companies reporting next week and what to look out for.
Lilly is soon planning to ask global regulators to approve tirzepatide for sleep apnea treatment. Is Eli Lilly stock a buy?